SQZ Biotechnologies
SQZ Biotechnologies was a company that specialized in cell engineering, but has been acquired by STEMCELL Technologies.
/10
Transparency ranking
Work at SQZ Biotechnologies?
Tell us what we're missing about working at SQZ Biotechnologies so we can make the job search more transparent for everyone.
Tell us what it's like to work at SQZ Biotechnologies!Description
SQZ Biotechnologies Company was a biotechnology company specializing in cell engineering. The company developed the Cell Squeeze® technology, a proprietary method for delivering therapeutic agents into cells. SQZ Biotechnologies was headquartered in Wayland, Massachusetts, and focused on developing novel therapies for various diseases.
On March 4, 2024, SQZ Biotechnologies sold its assets, including intellectual property and the Cell Squeeze® technology, to STEMCELL Technologies Canada Acquisitions, Inc. This acquisition marked the end of SQZ Biotechnologies as an independent company, and STEMCELL Technologies is now responsible for developing and commercializing the Cell Squeeze® technology.
Mission
SQZ Biotechnologies Company has been dissolved and its assets, including the Cell Squeeze® technology, have been acquired by STEMCELL Technologies. The company's mission was to develop cell-based therapies for various diseases using its proprietary Cell Squeeze® technology. However, this technology has been acquired by STEMCELL Technologies, which continues to develop cell engineering advancements, including the CellPore™ Transfection System.
Similar companies. But verified.
